Please login to the form below
Lipitor
The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lipitor was produced by Pfizer and Astellas.
Too much success
They will have no shortage of demand and might even dwarf Humira, Lipitor and other historic blockbusters.
Retrospective prospective
iPhone. Within pharma, the cholesterol- lowering drug Lipitor was about to become the best-selling pharmaceutical drug and worldwide pharmaceutical sales were less than a third of what they are today.
Pfizer set to unveil Mylan merger and spin-off
Its biggest off-patent brands would include drugs such as Pfizer’s Lipitor, Viagra and Mylan’s Epipen.
The handover: Pfizer reshapes itself for a new era
autonomous. Created in the summer reshuffle, the Established Medicines division includes the majority of Pfizer’s off-patent blockbuster pills, including Lyrica, Lipitor, Norvasc and Viagra, and a number of other
Pfizer names next CEO as Read retires
Ian Read’s tenure has had plenty of ups and downs, and undoubtedly one of his biggest challenges was overcoming the patent expiry of its mega-blockbuster Lipitor in November 2011. ... Pfizer slipped down the rankings in the years following the loss of
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
- 10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm
- Merck announces partnerships worth $1.3bn with BenevolentAI and Exscientia
- EC approves Menarini Group’s Orserdu for advanced or metastatic breast cancer
- Eli Lilly files US lawsuits over ‘unlawful’ sales of Mounjaro counterfeits
- Takeda announces CHMP recommendation for Adcetris in Hodgkin lymphoma
- MIT study reveals why certain immunotherapies do not always work
No results were found
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
